View in EDS

Bevacizumab mitigates codon-specific effects of trifluridine/tipiracil on efficacy outcome parameters in metastatic colorectal cancer.

Saved in:
Bibliographic Details
Title: Bevacizumab mitigates codon-specific effects of trifluridine/tipiracil on efficacy outcome parameters in metastatic colorectal cancer.
Authors: Doleschal B; Department of Internal Medicine I for Hematology with Stem Cell Transplantation, Hemostaseology, and Medical Oncology, Ordensklinikum Linz, Linz. Electronic address: bernhard.doleschal@ordensklinikum.at., Taghizadeh H; Department of Internal Medicine, Universitätsklinikum St. Pölten, Karl Landsteiner University of Health Sciences, St. Pölten., Lentner T; Department of Internal Medicine, Universitätsklinikum St. Pölten, Karl Landsteiner University of Health Sciences, St. Pölten., Riedl JM; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz., Granitzer J; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz., Morariu D; Department of Internal Medicine, State Hospital Wiener Neustadt, Wiener Neustadt., Decker J; Department of Internal Medicine, State Hospital Rohrbach, Rohrbach., Aichberger KJ; Department of Internal Medicine, State Hospital Rohrbach, Rohrbach., Webersinke G; Laboratory for Molecular Genetic Diagnostics, Ordensklinikum Linz, Linz., Kirchweger P; Department of General and Visceral Surgery, Ordensklinikum Linz, Linz; Medical Faculty, Johannes Kepler University Linz, Linz; Gastrointestinal Cancer Center, Ordensklinikum Linz, Linz, Austria., Petzer A; Department of Internal Medicine I for Hematology with Stem Cell Transplantation, Hemostaseology, and Medical Oncology, Ordensklinikum Linz, Linz., Rumpold H; Medical Faculty, Johannes Kepler University Linz, Linz; Gastrointestinal Cancer Center, Ordensklinikum Linz, Linz, Austria.
Source: ESMO open [ESMO Open] 2023 Dec; Vol. 8 (6), pp. 102064. Date of Electronic Publication: 2023 Nov 16.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37977001
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Bevacizumab mitigates codon-specific effects of trifluridine/tipiracil on efficacy outcome parameters in metastatic colorectal cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Doleschal+B%22">Doleschal B</searchLink>; Department of Internal Medicine I for Hematology with Stem Cell Transplantation, Hemostaseology, and Medical Oncology, Ordensklinikum Linz, Linz. Electronic address: bernhard.doleschal@ordensklinikum.at.<br /><searchLink fieldCode="AU" term="%22Taghizadeh+H%22">Taghizadeh H</searchLink>; Department of Internal Medicine, Universitätsklinikum St. Pölten, Karl Landsteiner University of Health Sciences, St. Pölten.<br /><searchLink fieldCode="AU" term="%22Lentner+T%22">Lentner T</searchLink>; Department of Internal Medicine, Universitätsklinikum St. Pölten, Karl Landsteiner University of Health Sciences, St. Pölten.<br /><searchLink fieldCode="AU" term="%22Riedl+JM%22">Riedl JM</searchLink>; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz.<br /><searchLink fieldCode="AU" term="%22Granitzer+J%22">Granitzer J</searchLink>; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz.<br /><searchLink fieldCode="AU" term="%22Morariu+D%22">Morariu D</searchLink>; Department of Internal Medicine, State Hospital Wiener Neustadt, Wiener Neustadt.<br /><searchLink fieldCode="AU" term="%22Decker+J%22">Decker J</searchLink>; Department of Internal Medicine, State Hospital Rohrbach, Rohrbach.<br /><searchLink fieldCode="AU" term="%22Aichberger+KJ%22">Aichberger KJ</searchLink>; Department of Internal Medicine, State Hospital Rohrbach, Rohrbach.<br /><searchLink fieldCode="AU" term="%22Webersinke+G%22">Webersinke G</searchLink>; Laboratory for Molecular Genetic Diagnostics, Ordensklinikum Linz, Linz.<br /><searchLink fieldCode="AU" term="%22Kirchweger+P%22">Kirchweger P</searchLink>; Department of General and Visceral Surgery, Ordensklinikum Linz, Linz; Medical Faculty, Johannes Kepler University Linz, Linz; Gastrointestinal Cancer Center, Ordensklinikum Linz, Linz, Austria.<br /><searchLink fieldCode="AU" term="%22Petzer+A%22">Petzer A</searchLink>; Department of Internal Medicine I for Hematology with Stem Cell Transplantation, Hemostaseology, and Medical Oncology, Ordensklinikum Linz, Linz.<br /><searchLink fieldCode="AU" term="%22Rumpold+H%22">Rumpold H</searchLink>; Medical Faculty, Johannes Kepler University Linz, Linz; Gastrointestinal Cancer Center, Ordensklinikum Linz, Linz, Austria.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101690685%22">ESMO open</searchLink> [ESMO Open] 2023 Dec; Vol. 8 (6), pp. 102064. <i>Date of Electronic Publication: </i>2023 Nov 16.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101690685 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2059-7029 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220597029%22">20597029 </searchLink><i>NLM ISO Abbreviation: </i>ESMO Open <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37977001
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.esmoop.2023.102064
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 102064
    Titles:
      – TitleFull: Bevacizumab mitigates codon-specific effects of trifluridine/tipiracil on efficacy outcome parameters in metastatic colorectal cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Doleschal B
      – PersonEntity:
          Name:
            NameFull: Taghizadeh H
      – PersonEntity:
          Name:
            NameFull: Lentner T
      – PersonEntity:
          Name:
            NameFull: Riedl JM
      – PersonEntity:
          Name:
            NameFull: Granitzer J
      – PersonEntity:
          Name:
            NameFull: Morariu D
      – PersonEntity:
          Name:
            NameFull: Decker J
      – PersonEntity:
          Name:
            NameFull: Aichberger KJ
      – PersonEntity:
          Name:
            NameFull: Webersinke G
      – PersonEntity:
          Name:
            NameFull: Kirchweger P
      – PersonEntity:
          Name:
            NameFull: Petzer A
      – PersonEntity:
          Name:
            NameFull: Rumpold H
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2023 Dec
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 2059-7029
          Numbering:
            – Type: volume
              Value: 8
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: ESMO open
              Type: main
ResultId 1